Abstract
Introduction: A simple, sensitive and reliable sensor has been explored for the determination of Melatonin (MEL) using cyclic voltammetry (CV) and square wave voltammetry (SWV).
Method: Irreversible oxidation of MEL was found to proceed through an adsorption controlled pathway at the glassy carbon electrode. The quantitative estimation of MEL was performed using SWV in a linear concentration range of 5-200 µM with a sensitivity of 0.0437 µM/ µA and a limit of detection of 0.3432 µM. The proposed protocol was also applied for determining MEL content in pharmaceutical samples and recovery studies in human urine samples were also performed.
Result: The observed results demonstrated a good agreement with the stated values.
Keywords: Melatonin, glassy carbon electrode, voltammetry, oxidation, human urine.
Current Pharmaceutical Analysis
Title:Electrochemical Behavior of Melatonin and its Sensing in Pharmaceutical Formulations and in Human Urine
Volume: 13 Issue: 1
Author(s): Neeraj Kumar and Rajendra N. Goyal
Affiliation:
Keywords: Melatonin, glassy carbon electrode, voltammetry, oxidation, human urine.
Abstract:
Introduction: A simple, sensitive and reliable sensor has been explored for the determination of Melatonin (MEL) using cyclic voltammetry (CV) and square wave voltammetry (SWV).
Method: Irreversible oxidation of MEL was found to proceed through an adsorption controlled pathway at the glassy carbon electrode. The quantitative estimation of MEL was performed using SWV in a linear concentration range of 5-200 µM with a sensitivity of 0.0437 µM/ µA and a limit of detection of 0.3432 µM. The proposed protocol was also applied for determining MEL content in pharmaceutical samples and recovery studies in human urine samples were also performed.
Result: The observed results demonstrated a good agreement with the stated values.
Export Options
About this article
Cite this article as:
Kumar Neeraj and Goyal N. Rajendra, Electrochemical Behavior of Melatonin and its Sensing in Pharmaceutical Formulations and in Human Urine, Current Pharmaceutical Analysis 2017; 13 (1) . https://dx.doi.org/10.2174/1573412912666160422154459
DOI https://dx.doi.org/10.2174/1573412912666160422154459 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Ligand Docking and Structure-based Virtual Screening in Drug Discovery
Current Topics in Medicinal Chemistry Impact of Anabolic Androgenic Steroids on Neuropeptide Systems
Mini-Reviews in Medicinal Chemistry Practical Considerations in the Development of Hemoglobin-Based Oxygen Therapeutics
Current Drug Discovery Technologies Elastic Liposomes Mediated Transdermal Delivery of An Anti-Jet Lag Agent:Preparation, Characterization and In Vitro Human Skin Transport Study
Current Drug Delivery Computer-Aided Discovery in Antimicrobial Research: In Silico Model for Virtual Screening of Potent and Safe Anti-Pseudomonas Agents
Combinatorial Chemistry & High Throughput Screening Peptides and their Metal Complexes in Neurodegenerative Diseases: from Structural Studies to Nanomedicine Prospects
Current Medicinal Chemistry Targeted D4 Dopamine Receptors: Implications for Drug Discovery and Therapeutic Development
Current Drug Targets Update on the Pharmacological Treatment of Pathological Gambling
Current Psychopharmacology New Trends in the Development of Oral Antidiabetic Drugs
Current Medicinal Chemistry Increasing Access to HIV Testing for Women by Simplifying Pre- and Post-Test Counseling
Current Women`s Health Reviews The Amyloid β-Protein Precursor and Alzheimers Disease. Therapeutic Approaches
Current Medicinal Chemistry - Central Nervous System Agents Polyploidy: The Link Between Senescence and Cancer
Current Pharmaceutical Design Mimicking Microvascular Alterations of Human Diabetic Retinopathy: A Challenge for the Mouse Models
Current Medicinal Chemistry Beta-Blocking Agents and Electroconvulsive Therapy
Current Drug Therapy Editorial: Signaling Molecules as Biomarkers and Therapeutic Targets for Alzheimer's Disease: A New Perspective
Current Alzheimer Research Mesenchymal Stem Cells Promote Caspase Expression in Molt-4 Leukemia Cells <i>Via</i> GSK-3α/Β and ERK1/2 Signaling Pathways as a Therapeutic Strategy
Current Gene Therapy Activation of the Innate Immune System in Atherosclerotic Disease
Current Pharmaceutical Design Solution NMR Study of the Transmembrane Domain of Single-Span Membrane Proteins: Opportunities and Strategies
Current Protein & Peptide Science A Spectrum of Topics for 2019: Advances in Neuroinflammation, Oxidative Stress, Obesity, Diabetes Mellitus, Cardiovascular Disease, Autism, Exosomes, and Central Nervous System Diseases
Current Pharmaceutical Design Appraisal of Anti-Arthritic and Anti-Inflammatory Potential of Folkloric Medicinal Plant <i>Peganum harmala</i>
Endocrine, Metabolic & Immune Disorders - Drug Targets